RussoMassimo Cancer Research UK Manchester Institute - The University of Manchester United Kingdom

I am a postdoctoral scientist at the Cancer Research UK Manchester Institute. Here, I explore the role of the immune system in metastasis formation, identifying the signals that promote immune escape and facilitate cancer dissemination by suppressing anti-tumour inflammatory responses.

Wednesday, 18 June 2025

Time	Session

18:15 18:40	Posters in the Spotlight - Wednesday dos Santos DiasMatheus Moderator The Netherlands Dissecting ovarian cancer cellular responses to radioimmunotherapy with β- particle and ultra-short range conversion and Auger electron-emitting radionuclides. (EACR25-0133) P-552 EACR25-0133 GrzmilMichal Presenter Switzerland Pan-cancer analysis of successive whole genome duplication in the 100,000 Genomes Project (EACR25-0555) P-746 EACR25-0555 SmythEvie Presenter Ireland COX-2/PGE2 Activity in Cancer Cells: A Key Driver of Metastasis via Immune Escape (EACR25-0743) P-773 EACR25-0743 RussoMassimo Presenter United Kingdom Depleting tumour-infiltrating Tregs to enhance the efficacy of KRAS-mutant targeted therapies in lung cancer (EACR25-1513) P-790 EACR25-1513 de CastroAndrea Presenter United Kingdom Cytotoxic ILC-1 cells determine outcome of PD-(L)1 blockade in microsatellite instable cancers (EACR25-2039) P-522 EACR25-2039 Van RoyenPaula Presenter Netherlands Spotlight Theatre

Time

Session

18:15

18:40

Posters in the Spotlight - Wednesday

dos Santos DiasMatheus Moderator The Netherlands

Dissecting ovarian cancer cellular responses to radioimmunotherapy with β- particle and ultra-short range conversion and Auger electron-emitting radionuclides. (EACR25-0133)

P-552

EACR25-0133

GrzmilMichal Presenter Switzerland
Pan-cancer analysis of successive whole genome duplication in the 100,000 Genomes Project (EACR25-0555)

P-746

EACR25-0555

SmythEvie Presenter Ireland
COX-2/PGE2 Activity in Cancer Cells: A Key Driver of Metastasis via Immune Escape (EACR25-0743)

P-773

EACR25-0743

RussoMassimo Presenter United Kingdom
Depleting tumour-infiltrating Tregs to enhance the efficacy of KRAS-mutant targeted therapies in lung cancer (EACR25-1513)

P-790

EACR25-1513

de CastroAndrea Presenter United Kingdom
Cytotoxic ILC-1 cells determine outcome of PD-(L)1 blockade in microsatellite instable cancers (EACR25-2039)

P-522

EACR25-2039

Van RoyenPaula Presenter Netherlands

Spotlight Theatre